| Literature DB >> 20711173 |
Ralf Schröder1, Nicole Janssen, Johannes Schmidt, Anna Kebig, Nicole Merten, Stephanie Hennen, Anke Müller, Stefanie Blättermann, Marion Mohr-Andrä, Sabine Zahn, Jörg Wenzel, Nicola J Smith, Jesús Gomeza, Christel Drewke, Graeme Milligan, Klaus Mohr, Evi Kostenis.
Abstract
Label-free biosensor technology based on dynamic mass redistribution (DMR) of cellular constituents promises to translate GPCR signaling into complex optical 'fingerprints' in real time in living cells. Here we present a strategy to map cellular mechanisms that define label-free responses, and we compare DMR technology with traditional second-messenger assays that are currently the state of the art in GPCR drug discovery. The holistic nature of DMR measurements enabled us to (i) probe GPCR functionality along all four G-protein signaling pathways, something presently beyond reach of most other assay platforms; (ii) dissect complex GPCR signaling patterns even in primary human cells with unprecedented accuracy; (iii) define heterotrimeric G proteins as triggers for the complex optical fingerprints; and (iv) disclose previously undetected features of GPCR behavior. Our results suggest that DMR technology will have a substantial impact on systems biology and systems pharmacology as well as for the discovery of drugs with novel mechanisms.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20711173 DOI: 10.1038/nbt.1671
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908